Chong Kun Dang Pharmaceutical

This study tested a new medicine called CertiroBell® against a standard anti-rejection drug (mycophenolate mofetil) in 150 adults who received a liver transplant from a living donor. The goal was to see if CertiroBell® works as well or better at preventing organ rejection, graft …

This study looked at how a tacrolimus tablet (TacroBell) works in 128 kidney transplant patients. The goal was to measure drug levels in the blood and see how well patients tolerated the medicine. Tacrolimus is an immunosuppressant taken long-term to prevent organ rejection, so t…